RLMD
Relmada Therapeutics IncNASDAQ
Healthcare • Biotechnology
Updated 1 day ago
Coverage limited
Factor tilt: Anti-Quality Small Cap
$3.36-4.27%
Close Oct 13, 2026
- Market cap
- $352.43M
- 1 month
- -24.3%
- 3 months
- -45.9%
- 1 year
- +64.7%
- 52-week range
- $1.93$7.86
- Dividend
- No payments on record
- Next-quarter EPS estimate
- -$0.15Quarter to Sep 30, 2026 · 4 analysts · revenue $0
- Short interest
- 16.2% of float13.4M shares · settled Sep 30, 2026 · -7.2% since Sep 15, 2026 · FINRA
Fundamentals · trailing 12 months to Jun 30, 2026
- Revenue
- —
- Net income
- -$61.93M
- Free cash flow
- -$45.99M
- Book value
- $206.56M
- Total debt
- —
- P/E
- —
- Price / sales
- —
- Price / book
- 1.7×
- FCF yield
- -13.0%
- Net margin
- —
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if RLMD is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
41 top institutions tracked
as of 2026-Q2 (filed 2026-09-22)
Last 13F trend: distributing (light)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: bullish
Last trade: buy 33 days ago
Red flags: 0
Largest 13-F holders · Q2 2026
126 filers reported a long position in RLMD for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Jupiter Topco LLC | $77.3M | 11.2M | — |
| BlackRock, Inc. | $51.4M | 7.4M | +475.9% |
| Squadron Capital Management LLC | $50.9M | 7.4M | -13.3% |
| Venrock Adviser, LLC | $47.4M | 6.8M | +41.3% |
| Spruce Street Capital LP | $44.2M | 6.4M | +2.1% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $33M | 4.8M | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $30.9M | 4.5M | +45% |
| Jones Hill Capital LP | $25.3M | 3.7M | +966.4% |
| ORBIMED ADVISORS LLC | $25.1M | 3.6M | -23% |
| STATE STREET CORP | $17.4M | 2.5M | +605.1% |
Get the Full Analysis for RLMD
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.
Similar-size companies in Healthcare
EIKN · Eikon Therapeutics, Inc. Common StockMPLT · MapLight Therapeutics, Inc. Common StockEBS · Emergent Biosolutions IncFENC · Fennec Pharmaceuticals IncKYTX · Kyverna Therapeutics, Inc. Common StockVTVT · vTv Therapeutics IncSY · So-Young International IncARCT · Arcturus Therapeutics Holdings Inc